- Home
- AWK vs RMD Comparison
AWK vs RMD Comparison
Compare AWK & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWK
- RMD
- Stock Information
- Founded
- AWK 1886
- RMD 1989
- Country
- AWK United States
- RMD United States
- Employees
- AWK N/A
- RMD N/A
- Industry
- AWK Water Supply
- RMD Medical/Dental Instruments
- Sector
- AWK Utilities
- RMD Health Care
- Exchange
- AWK Nasdaq
- RMD Nasdaq
- Market Cap
- AWK 27.4B
- RMD 31.8B
- IPO Year
- AWK 2008
- RMD 1995
- Fundamental
- Price
- AWK $148.40
- RMD $212.91
- Analyst Decision
- AWK Hold
- RMD Buy
- Analyst Count
- AWK 9
- RMD 11
- Target Price
- AWK $143.11
- RMD $253.88
- AVG Volume (30 Days)
- AWK 1.8M
- RMD 1.2M
- Earning Date
- AWK 04-30-2025
- RMD 04-23-2025
- Dividend Yield
- AWK 2.08%
- RMD 1.00%
- EPS Growth
- AWK 10.19
- RMD 40.24
- EPS
- AWK 5.39
- RMD 8.47
- Revenue
- AWK $4,684,000,000.00
- RMD $4,926,773,000.00
- Revenue This Year
- AWK $6.28
- RMD $10.09
- Revenue Next Year
- AWK $6.89
- RMD $7.39
- P/E Ratio
- AWK $27.53
- RMD $25.14
- Revenue Growth
- AWK 10.63
- RMD 9.38
- 52 Week Low
- AWK $113.53
- RMD $172.19
- 52 Week High
- AWK $155.50
- RMD $263.05
- Technical
- Relative Strength Index (RSI)
- AWK 58.25
- RMD 44.79
- Support Level
- AWK $137.41
- RMD $206.74
- Resistance Level
- AWK $149.66
- RMD $217.38
- Average True Range (ATR)
- AWK 4.58
- RMD 8.87
- MACD
- AWK -0.06
- RMD 0.32
- Stochastic Oscillator
- AWK 60.75
- RMD 51.28
About AWK American Water Works Company Inc.
American Water Works is the largest investor-owned US water and wastewater utility, serving approximately 3.5 million customers in 16 states. It provides water and wastewater services to residential, commercial, and industrial customers and operates predominantly in regulated markets. The company's nonregulated business is water services for military bases, which operates under long-term contracts with regulated-like returns.
About RMD ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.